While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy
Frequently Asked Questions How long do headaches typically last when starting semaglutide
What happens if I stop taking GLP-1s
In order to ensure data quality, cases were removed if they failed two or more quality checks: (1) attention check questions in the online version of the questionnaire, (2) had over 30% item non-response, or (3) had a length less than one quarter of the mean length by mode
Despite prior authorization protocols, managing this class of medications is becoming increasingly challenging
New York Citys health insurer stopped covering GLP-1 drugs for city employees in 2025 while Bostons leaders are considering limiting such coverage for city employees because of an insurance rate hike largely driven by the GLP-1 drug cost
